NCT04792034View on ClinicalTrials.gov

Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

December 1, 2021

Conditions
ENT Disorder
Interventions
DRUG

Cocaine Hydrochloride Topical Solution

Topical Anesthetic

Sponsors
All Listed Sponsors
lead

Pharmaceutical Project Solutions, Inc.

INDUSTRY